• This record comes from PubMed

Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease

. 2013 Nov ; 463 (5) : 721-30. [epub] 20130920

Language English Country Germany Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Retroperitoneal fibrosis (RF) is a rare disease characterized by inflammation and fibrosis of retroperitoneal soft tissues. It is classified into two types: idiopathic (iRF) and secondary (sRF). The aim of the study was to investigate the relationship between iRF and IgG4-related disease (IgG4-RD) and to eventually extend the clinicopathological features of this condition by analysis of the sample comprising six iRF and six sRF patients. The iRF patients included four males and two females, aged 12-62 years (median 55 years). Two lesions were periaortic, one was periureteral, and three cases showed both periaortic and periureteral localization. Two patients had increased serum levels of IgG4. None of the patients developed any manifestation of IgG4-RD during the follow-up period ranging for 15-133 months (median 43 months). Microscopically, in two iRF cases, fibrosis was highly cellular encircling the vessels, nerves, and paraganglia. Phlebitis was found in all cases and being obliterative in four. Lymphocytic inflammation with formation of follicles and plasma cell infiltration were scored as severe in five iRF cases. The numbers of IgG-positive plasma cells ranged 0-373 per 1 HPF (high power field; median 132) and of IgG4-positive plasma cells 0-238 per 1 HPF (median 91). The IgG4/IgG ratio values ranged 0.38-0.74 (median 0.68). Two of the iRF cases were diagnosed as definite and three cases as probable IgG4-RD. To the contrary, none of the sRF cases met the diagnostic criteria for either definite, probable, or possible IgG4-related disease. Our results indicate that a substantial portion of iRF cases, including some of very rare pediatric cases, is a manifestation of IgG4-RD.

See more in PubMed

Lancet. 2006 Jan 21;367(9506):241-51 PubMed

BMC Med. 2006 Oct 06;4:23 PubMed

Dig Dis Sci. 1995 Jul;40(7):1561-8 PubMed

Am J Surg Pathol. 2010 Dec;34(12):1812-9 PubMed

World J Gastroenterol. 2013 Jan 7;19(1):35-41 PubMed

Am J Surg Pathol. 2008 Apr;32(4):553-9 PubMed

Adv Anat Pathol. 2013 Jan;20(1):10-6 PubMed

Cesk Patol. 2010 Oct;46(4):82-5 PubMed

Pathol Res Pract. 2012 Apr 15;208(4):231-4 PubMed

Histol Histopathol. 2013 May;28(5):565-84 PubMed

Int J Surg Pathol. 2011 Apr;19(2):220-4 PubMed

Kidney Int. 2007 Sep;72(6):742-53 PubMed

Mod Pathol. 2011 Nov;24(11):1480-7 PubMed

Mod Pathol. 2011 Apr;24(4):606-12 PubMed

Cas Lek Cesk. 2011;150(8):438-41 PubMed

Mod Pathol. 2012 Sep;25(9):1181-92 PubMed

Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1078-94 PubMed

Hum Pathol. 2012 Apr;43(4):536-49 PubMed

Cardiovasc Pathol. 2011 Nov-Dec;20(6):352-60 PubMed

Mod Rheumatol. 2012 Feb;22(1):1-14 PubMed

Acta Medica (Hradec Kralove). 2012;55(1):42-6 PubMed

Rheum Dis Clin North Am. 2013 May;39(2):365-81 PubMed

J Pediatr Surg. 2003 Nov;38(11):1685-8 PubMed

Lancet. 2004 May 1;363(9419):1422-6 PubMed

Mod Rheumatol. 2012 Feb;22(1):21-30 PubMed

Hum Pathol. 2012 Nov;43(11):1875-80 PubMed

Curr Opin Rheumatol. 2005 Jan;17(1):34-40 PubMed

Histopathology. 2011 Jun;58(7):1157-63 PubMed

Arthritis Rheum. 2012 Oct;64(10):3061-7 PubMed

Histopathology. 2008 Feb;52(3):404-9 PubMed

N Engl J Med. 2012 Feb 9;366(6):539-51 PubMed

Arthritis Rheum. 2006 Feb 15;55(1):126-30 PubMed

Acta Neuropathol. 2010 Dec;120(6):765-76 PubMed

Semin Diagn Pathol. 2012 Nov;29(4):226-34 PubMed

Virchows Arch. 2013 Jun;462(6):673-8 PubMed

J Clin Pathol. 2012 Nov;65(11):963-9 PubMed

Am J Surg Pathol. 2009 Dec;33(12):1886-93 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...